#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adrenocortical carcinoma Meningitis meningococcal Ventricular tachycardia Chronic graft versus host disease in skin Colon cancer Penile squamous cell carcinoma Primitive neuroectodermal tumour Hereditary angioedema Arterial tortuosity syndrome Krabbe's disease Keratosis follicular Thymic carcinoma Blastic plasmacytoid dendritic cell neoplasia Porphyria non-acute Obesity More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis III Hereditary optic atrophy – Life with Disease Sarcoma – Basic Information Mastocytosis – Life with Disease Pemphigus Medulloblastoma recurrent – Basic Information Hereditary angioedema – Basic Information Phenylketonuria – Diagnostics Mast cell activation syndrome – Life with Disease Undifferentiated sarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Transpocart19 PICLIDENOSON AMMONIUM (15N) CHLORIDE Lanreotide Tezacaftor Quc398 Mirabegron Heterodimeric Interleukin-15 Vilanterol Camlipixant Pyrazinamide Resmetirom Chlortalidone Ibuprofen Lysine Tiotropium Bromide Dapansutrile GSKVX000000034795 Methadone Hydrochloride Tpst-1120 Tarlatamab More therapies…

    Learn about Your Condition

    PIK3CA-activated mutation Acute kidney injury Mantle cell lymphoma recurrent Deep vein thrombosis Urticaria chronic Cartilage injury Pancreatic neoplasm Chondrocalcinosis Osteomyelitis acute Pancreatic fistula Pancoast's tumour Asthmatic crisis Constipation Adenomyosis Pneumonia bacterial More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study of GSK3965193 and Bepirovirsen for People Living with Chronic Hepatitis B Infection and Healthy Participants

    Not recruiting

    2 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • Gsk3965193B
    • Bepirovirsen
    France Italy

  • Study of Influenza Vaccine Effects on Immune Response in the Nose and Airways in Adults Seeking Protection Against Seasonal Flu

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
    • A/Wisconsin/67/2022 (H1N1)Pdm09-Like Strain (A/Georgia/12/2022 Cvr-167)
    • B/Austria/1359417/2021-Like Strain (B/Singapore/Wuh4618/2021)
    France

  • A study of immune system response in adults who develop shingles after receiving recombinant herpes zoster vaccine to understand vaccine protection

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Herpes zoster
    Investigated Drugs:
    • Recombinant Varicella Zoster Virus Glycoprotein E
    Belgium

  • A Study Testing mRNA-1273 Vaccine Safety and Effectiveness Against Severe COVID-19 in Adults Aged 50-64 Years Without Risk Factors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Elasomeran
    Denmark

  • A Study to Test the Safety and Body’s Response to TETRALITE Influenza Vaccine Compared to Vaxigrip Tetra Vaccine in Healthy Adults Aged 18 to 50 Years

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • Influenza Virus B/Michigan/01/2021
    • A/Victoria/2570/2019 (H1N1)Pdm09-Like Strain (A/Victoria/2570/2019, Ivr-215)
    • B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type)
    Belgium

  • A study to test the safety and immune response of PHH-1V111 vaccine against COVID-19 variants in adults

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • COVID-19
    Spain
Previous Page
1 … 23 24 25 26 27 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!